Perinatal HIV-1 transmission -: Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

被引:201
作者
Mandelbrot, L
Le Chenadec, J
Berrebi, A
Bongain, M
Bénifla, JL
Delfraissy, JF
Blanche, S
Mayaux, MJ
机构
[1] Hop Cochin Port Royal, Serv Gynecol Obstet 1, F-75014 Paris, France
[2] INSERM, U149, Paris, France
[3] INSERM, U292, Le Kremlin Bicetre, France
[4] Hop La Grave, Serv Gynecol Obstet, Toulouse, France
[5] Hop Archet 2, Serv Gynecol Obstet, Nice, France
[6] Hop Bichat Claude Bernard, Serv Gynecol Obstet, F-75877 Paris, France
[7] Hop Kremlin Bicetre, Serv Med Interne, Le Kremlin Bicetre, France
[8] Hop Necker Enfants Malad, Serv Pediat, Paris, France
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 280卷 / 01期
关键词
D O I
10.1001/jama.280.1.55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-It is unclear whether elective cesarean delivery may have a protective effect against the transmission of human immunodeficiency virus 1 (HIV-1). Objective.-To investigate whether mode of delivery has an impact on perinatal HIV-1 transmission in the presence of zidovudine prophylaxis. Design.-A prospective cohort study. Setting.-The 85 perinatal centers in the French Perinatal Cohort, from 1985 to 1996. Patients.-A total of 2834 singleton children born to mothers with HIV-1 infection. Main Outcome Measure.-Human immunodeficiency virus 1 infection of the infant. Results.-No zidovudine was used in 1917 pregnancies and zidovudine prophylaxis was used in 902 pregnancies. Cesarean deliveries were performed in 10.9% on an emergent basis and in 8.3% electively, prior to labor or membrane rupture. In 1917 mothers who did not receive zidovudine, of 1877 with information on mode of delivery, 17.2% transmitted HIV-1 to their child. Risk factors statistically significantly associated with transmission were maternal p24 antigenemia, cervicovaginal infections during pregnancy, amniotic fluid color, and rupture of membranes 4 hours or more before delivery. Mode of delivery was not related to transmission. in 902 mothers receiving zidovudine, transmission was 6.4% in 872 with information on mode of delivery, and elective cesarean delivery (n = 133) was associated with a lower transmission rate than emergent cesarean or vaginal delivery (0.8%, 11.4%, and 6.6%, respectively; P=.002). In a multivariate analysis of all mother-child pairs, including obstetrical risk factors, maternal p24 antigenemia, and zidovudine prophylaxis, interaction between mode of delivery and zidovudine prophylaxis was significant (P=.007). In the multivariate analysis of pregnancies with zidovudine prophylaxis, factors related to transmission rate were maternal p24 antigenemia, amniotic fluid color, and mode of delivery. Adjusted odds ratios (95% confidence intervals) were 1.6 (0.7-3.6) for emergent cesarean delivery and 0.2 (0.0-0.9) for elective cesarean delivery (P =.04) in comparison with vaginal delivery. Conclusions.-We observed an interaction between zidovudine prophylaxis and elective cesarean delivery in decreasing transmission of HIV-1 from mother to child. This observation may have clinical implications for prevention.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 40 条
[11]  
Fiscus SA, 1996, JAMA-J AM MED ASSOC, V275, P1483, DOI 10.1001/jama.275.19.1483
[12]  
HOGBERG U, 1994, OBSTET GYNECOL, V84, P240
[13]   Prevention of vertical HIV transmission:: additive protective effect of elective Cesarean section and zidovudine prophylaxis [J].
Kind, C ;
Rudin, C ;
Siegrist, CA ;
Wyler, CA ;
Biedermann, K ;
Lauper, U ;
Irion, O ;
Schüpbach, J ;
Nadal, D .
AIDS, 1998, 12 (02) :205-210
[14]  
KIND C, 1995, EUR J PEDIATR, V154, P542, DOI 10.1007/BF02074831
[15]   Timing of maternal-infant HIV transmission: Associations between intrapartum factors and early polymerase chain reaction results [J].
Kuhn, L ;
Abrams, EJ ;
Matheson, PB ;
Thomas, PA ;
Lambert, G ;
Bamji, M ;
Greenberg, B ;
Steketee, RW ;
Thea, DM ;
Beatrice, ST ;
Chiasson, MA ;
DeBernardo, E ;
Hutchison, S ;
McVeigh, K ;
Oleszko, W ;
Punsalang, A ;
Alford, T ;
Betre, A ;
Cappelli, M ;
Carrasquillio, N ;
Cruz, N ;
Floyd, J ;
FoyeSousou, V ;
Jessop, DJ ;
Macias, L ;
Ng, D ;
Nelson, K ;
Rios, J ;
Pliner, V ;
Rosenbluth, L ;
Hodge, R ;
Tadros, H ;
Weedon, J ;
Young, S ;
Zhang, ZR ;
Courtland, R ;
Daligadu, M ;
Hoover, W ;
Lopez, D ;
Pollack, H ;
Krasinski, K ;
Belmore, A ;
Champion, S ;
Freedland, C ;
Lovich, S ;
Prince, P ;
Rogers, A ;
Suarez, M ;
Chow, J ;
Kaul, A .
AIDS, 1997, 11 (04) :429-435
[16]   MATERNAL-INFANT HIV TRANSMISSION AND CIRCUMSTANCES OF DELIVERY [J].
KUHN, L ;
STEIN, ZA ;
THOMAS, PA ;
SINGH, T ;
TSAI, WY .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (07) :1110-1115
[17]   Obstetrical factors and the transmission of human immunodeficiency virus type I from mother to child [J].
Landesman, SH ;
Kalish, LA ;
Burns, DN ;
Minkoff, H ;
Fox, HE ;
Zorrilla, C ;
Garcia, P ;
Fowler, MG ;
Mofenson, L ;
Tuomala, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (25) :1617-1623
[18]   Least microtransfusion from mother to fetus in elective cesarean delivery [J].
Lin, HH ;
Kao, JH ;
Hsu, HY ;
Mizokami, M ;
Hirano, K ;
Chen, DS .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (02) :244-248
[19]   HIV-1 detection in cervicovaginal secretions during pregnancy [J].
LoussertAjaka, I ;
Mandelbrot, L ;
Delmas, MC ;
Bastian, H ;
Benifla, JL ;
Farfara, I ;
deVincenzi, I ;
Matheron, S ;
Simon, F ;
BrunVezinet, F .
AIDS, 1997, 11 (13) :1575-1581
[20]  
Mandelbrot L, 1996, AM J OBSTET GYNECOL, V175, P661